Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$13.85−$0.2700 (−1.91%) on the dayAs of the close; data may be delayed.
ARCT price, last 12 months
Key stats
- Previous close
- $14.12
- Open
- $14.34
- Day range
- $13.30 – $14.48
- 52-week range
- $5.50 – $24.17
- Volume
- 629.9K
- Avg volume (20 days)
- 994.7K
- Market cap
- $393.7M
Performance
1W−13.6%
1M−12.5%
3M+101.3%
6M+95.6%
YTD+125.9%
1Y−32.3%
vs S&P 500, 1Y−49.1 pts
Technicals and fundamentals
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $393.7M